日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Therapeutic Benefit Ratings for FDA Breakthrough-Designated Devices

FDA突破性医疗器械的治疗获益评级

Kadakia, Kushal T; Swoboda, Christine M; Moneer, Osman; Dhruva, Sanket S; Ross, Joseph S; Krumholz, Harlan M; Burke, James F; Rathi, Vinay K

P-1611. Longitudinal Measurement of Peripheral Blood Cytokines and COVID-19 Severity and Long COVID Outcomes in the EPIC3 Study

P-1611. EPIC3研究中外周血细胞因子与COVID-19严重程度和长期COVID结局的纵向测量

Vincelette, J; Baril, J G; Allard, R; Mendall, Calen; Li, Xumin; Pakanati, Vivek; Liu, Cindy H; Wang, Tracy; Morelli, Daniel; Korpak, Anna; Baraff, Aaron; Isaacs, Stuart N; Vittor, Amy; Chang, Kyong-Mi; Le, Elizabeth; Smith, Nicholas L; Lee, Jennifer S; Ross, Jennifer M; Shah, Javeed

Revenue, Patents, and New Generic Competition for Prescription Drugs in the USA

美国处方药的收入、专利和新仿制药竞争

Tu, S Sean; Kesselheim, Aaron S; Ross, Joseph S; Gupta, Ravi

Modeling In-Hospital Mortality Among Patients Undergoing Percutaneous Coronary Intervention with Acute Myocardial Infarction Complicated by Cardiogenic Shock Receiving Mechanical Circulatory Support

对接受机械循环支持治疗的急性心肌梗死合并心源性休克患者进行经皮冠状动脉介入治疗后的院内死亡率进行建模

Hurley, Nathan C; Mortazavi, Bobak J; Dhruva, Sanket S; Ross, Joseph S; Ngufor, Che G; Curtis, Jeptha P; Krumholz, Harlan M; Desai, Nihar R

Variant-to-gene mapping identifies ARHGEF12 as a primary open-angle glaucoma effector gene operating within retinal ganglion cells

变异-基因映射分析表明,ARHGEF12 是视网膜神经节细胞内发挥作用的主要开角型青光眼效应基因。

Vrathasha, Vrathasha; Pahl, Matthew C; Pippin, James A; Nikonov, Sergei; He, Jie; Halimitabrizi, Mina; Moksha, Laxmi; Salowe, Rebecca; Edziah, Amy-Ann; Bradford, Yuki; Zhu, Yan; Gudiseva, Harini V; Chavali, Venkata R M; Lopes da Costa, Bruna; Berry, Anne Marie; Quinn, Peter M J; Cui, Qi N; Miller-Ellis, Eydie; Sankar, Prithvi S; Ross, Ahmara G; Addis, Victoria; Verma, Shefali S; Wells, Andrew D; Grant, Struan F A; O'Brien, Joan M

A functional microbiome catalogue crowdsourced from North American rivers

北美河流众包构建的功能性微生物组目录

Borton, Mikayla A; McGivern, Bridget B; Willi, Kathryn R; Woodcroft, Ben J; Mosier, Annika C; Singleton, Derick M; Bambakidis, Ted; Pelly, Aaron; Daly, Rebecca A; Liu, Filipe; Freiburger, Andrew; Edirisinghe, Janaka N; Faria, José P; Danczak, Robert; Leleiwi, Ikaia; Goldman, Amy E; Wilkins, Michael J; Hall, Ed K; Pennacchio, Christa; Roux, Simon; Eloe-Fadrosh, Emiley A; Good, Stephen P; Sullivan, Matthew B; Wood-Charlson, Elisha M; Miller, Christopher S; Ross, Matthew R V; Henry, Christopher S; Crump, Byron C; Stegen, James C; Wrighton, Kelly C

FDA Authorization of Therapeutic Devices Under the Breakthrough Devices Program

FDA突破性医疗器械计划下的治疗器械授权

Kadakia, Kushal T; Dhruva, Sanket S; Ross, Joseph S; Burke, James F; Johnston, James L; Ramachandran, Reshma; Krumholz, Harlan M; Rathi, Vinay K

Somatic mtDNA mutation burden shapes metabolic plasticity in leukemogenesis

体细胞线粒体DNA突变负荷影响白血病发生过程中的代谢可塑性

Xiujie Li-Harms ,Jingjun Lu ,Yu Fukuda ,John Lynch ,Aditya Sheth ,Gautam Pareek ,Marcin M Kaminski ,Hailey S Ross ,Christopher W Wright ,Amber L Smith ,Huiyun Wu ,Yong-Dong Wang ,Marc Valentine ,Geoffrey Neale ,Peter Vogel ,Stanley Pounds ,John D Schuetz ,Min Ni ,Mondira Kundu

Hospital Acquisition Costs for Breakthrough-Designated Devices Awarded Supplemental Medicare Reimbursement

医院购置获得突破性医疗器械并获补充医疗保险报销的费用

Moneer, Osman; Kadakia, Kushal T; Dhruva, Sanket S; Ross, Joseph S; Roth, Leah M; Burke, James F; Rathi, Vinay K

Research Derived From Medicare's Coverage With Evidence Development Program

源自医疗保险循证发展计划的研究

Janda, Guneet S; Moneer, Osman; Mooghali, Maryam; Ramachandran, Reshma; Wallach, Joshua D; Dhruva, Sanket S; Ross, Joseph S